You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 22, 2024

Litigation Details for Mayne Pharma International Pty Ltd. v. Actavis Elizabeth LLC (D. Del. 2017)

✉ Email this page to a colleague

« Back to Dashboard

Mayne Pharma International Pty Ltd. v. Actavis Elizabeth LLC (D. Del. 2017)

Docket	⤷ Sign Up	Date Filed	2017-11-09
Court	District Court, D. Delaware	Date Terminated	2019-01-23
Cause	35:271 Patent Infringement	Assigned To	Mitchell S. Goldberg
Jury Demand	None	Referred To	Richard A. Lloret
Parties	TEVA PHARMACEUTICALS USA, INC.
Patents	6,958,161; 9,295,652; 9,446,057; 9,511,031
Attorneys	Yiye Fu
Firms	Morris, Nichols, Arsht & Tunnell
Link to Docket	External link to docket

Small Molecule Drugs cited in Mayne Pharma International Pty Ltd. v. Actavis Elizabeth LLC

The small molecule drugs covered by the patents cited in this case are ⤷ Sign Up and ⤷ Sign Up .

Details for Mayne Pharma International Pty Ltd. v. Actavis Elizabeth LLC (D. Del. 2017)

+ Get email alerts for changes to this table

Subscribe to access the full database, or Sign Up
Date Filed	Document No.	Description	Snippet	Link To Document
0000-00-00				External link to document
2017-11-08	1		expiration of United States Patent No. 6,958,161 (“the ’161 Patent”); United States Patent No. 9,295,652 (“the…’652 Patent”); United States Patent No. 9,446,057 (“the ’057 Patent”); and United States Patent No. 9,511,031…infringement of the ’161 Patent, the ’652 Patent, the ’057 Patent, and the ’031 Patent. 12. This…Mayne owns the ’161 Patent, the ’652 Patent, the ’057 Patent, and the ’031 Patent. … 23. The ’161 Patent, the ’652 Patent, the ’057 Patent, and the ’031 Patent are listed in the Approved	External link to document
2017-11-08	3		or about 10/2/2017. Date of Expiration of Patent: 6,958,161 - 12/12/2022; 9,295,652 - 10/23/2034; 9,446,057… Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) …2017 23 January 2019 1:17-cv-01614 835 Patent - Abbreviated New Drug Application(ANDA) None	External link to document
2017-11-08	4		the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 6,958,161 B2; 9,295,652 B1; 9,446,057…2017 23 January 2019 1:17-cv-01614 835 Patent - Abbreviated New Drug Application(ANDA) None	External link to document
2019-01-22	98		the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 6,958,161 B2; 9,295,652 B1; 9,446,057…2017 23 January 2019 1:17-cv-01614 835 Patent - Abbreviated New Drug Application(ANDA) None	External link to document
>Date Filed	>Document No.	>Description	>Snippet	>Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.